𝔖 Bobbio Scriptorium
✦   LIBER   ✦

314 APPLICATION OF RECOMBINANT HUMAN INTERLEUKIN 2 IN THE TREATMENT OF CHILDREN WITH CHRONIC HEPATITIS C

✍ Scribed by G. Volynets; N. Pakhomovskaya; A. Potapov

Book ID
117379459
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
56 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A pilot study of recombinant interleukin
A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C
✍ M Pardo; I Castillo; H Oliva; A Fernandez-Flores; R Barcena; M A de Peuter; V Ca πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 178 KB πŸ‘ 1 views

The optimal and safer interleukin-2 (IL-2) dose for treatment of chronic hepatitis C virus (HCV) infection has been studied in 33 HCV-RNA positive patients with chronic hepatitis C. Patients were randomly allocated to receive 5 days per week during 12 weeks IL-2 doses of: 0.9 MIU (n = 10), 1.8 MIU (

Treatment of children with chronic hepat
Treatment of children with chronic hepatitis C with recombinant interferon-Ξ±: A pilot study
✍ Mercedes Ruiz-Moreno; Maria JosΓ© Rua; Inmaculada Castillo; Maria Dolores GarcΓ­a- πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 424 KB πŸ‘ 1 views

Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6